EMA Seeks Clarity On Generics Of Drugs Approved Under Exceptional Circumstances
Executive Summary
The European Medicines Agency has asked the European Commission to clarify whether generics of drugs authorized under exceptional circumstances should be subject to the same obligations as the reference product.